BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.630
+0.040 (1.11%)
At close: Sep 1, 2026, 4:00 PM EDT
3.550
-0.080 (-2.20%)
After-hours: Sep 1, 2026, 7:44 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$1,917,204
Market Cap
31.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% | 16 | 0 |
| Jul 31, 2021 | 6 | 0 | - | 5 | 1 |
| Aug 1, 2019 | 6 | - | - | 5 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Quince Therapeutics | 38 |
| Kyntra Bio | 34 |
| Actinium Pharmaceuticals | 27 |
| Context Therapeutics | 15 |
| Barinthus Biotherapeutics | 14 |
| TransCode Therapeutics | 12 |
| NanoViricides | 7 |
BCTX News
- 8 days ago - BriaCell advances melanoma immunotherapy vaccine candidate Bria-MEL+ - TheFly
- 8 days ago - BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™ - GlobeNewsWire
- 27 days ago - BriaCell gets FDA clearance for Bria-PROS+ study in prostate cancer - TheFly
- 27 days ago - BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer - GlobeNewsWire
- 6 weeks ago - BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site - GuruFocus
- 6 weeks ago - BriaCell announces Odette Cancer Centre joins Bria-IMT trial - TheFly
- 6 weeks ago - BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer - GlobeNewsWire
- 6 weeks ago - BriaCell (BCTX) Partners with Fujifilm for Cell Therapy Manufacturing - GuruFocus